glp 1 nejm Access to GLP-1s for Medicare Beneficiaries — A Bridge to Nowhere? NEJM Clinician: Should we hold

They do not produce 15 to 22 percent body weight loss over 68 to 72 weeks

(R-KS) sent a bipartisan letter to the FDA flagging Hims & Hers' ad and accusing the company of misleading patients "by omitting any safety or side effect information when promoting a specific type of weight loss medication." Under federal law and regulations, FDA requires that prescription drug advertisements be truthful, not misleading, and balancedfailure to do so risks FDA enforcement action, including civil monetary penalties, Durbin and Marshall said in the letter

Buccarelli, M

Traditional cardiovascular risk calculators underestimate risk in lupus patients because they were not designed for populations with chronic systemic inflammation

They are not built for the specific nutrition questions that come up on a GLP-1: did appetite drop without protein keeping up, did a low-fiber stretch precede the constipation, did dehydration sit underneath the fatigue